Pfm Health Sciences, LP Coherus Bio Sciences, Inc. Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $7.17 Million - $8.19 Million	-411,727 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $899,393 - $1.19 Million	-62,328 Reduced 13.15%	411,727 $7.35 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $712,231 - $1.38 Million	-61,031 Reduced 11.41%	474,055 $7.69 Million
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $2.53 Million - $3.31 Million	-154,739 Reduced 22.43%	535,086 $9.63 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $12.5 Million - $18 Million	-768,160 Reduced 52.69%	689,825 $14 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $6.69 Million - $11.3 Million	510,924 Added 53.95%	1,457,985 $32.2 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $7.94 Million - $14.7 Million	947,061 New	947,061 $12.9 Million

133

70M

1.16M

39.5K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.